According to published studies, tight junction and stratum corneum protein gene expressions, including CLDN-1, OCLN, FLG-1, and FLG-2 in the skin of patients with severe ACD, are downregulated [44]. The gene discussed is FLG2; the disease is granular corneal dystrophy type II.